Entasis Therapeutics Holdings Inc.

CIK 1724344 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Entasis Therapeutics Holdings Inc..

Recent SEC filings

FiledFormAccession number
Jul 21, 202215-12G0001140361-22-026612
Jul 13, 202240001140361-22-025957
Jul 12, 2022EFFECT9999999995-22-002023
Jul 12, 2022EFFECT9999999995-22-002020
Jul 12, 2022EFFECT9999999995-22-002021
Jul 12, 2022EFFECT9999999995-22-002024
Jul 11, 202240001104659-22-078796
Jul 11, 202240001104659-22-078787
Jul 11, 202240001104659-22-078803
Jul 11, 202240001104659-22-078797
Jul 11, 202240001104659-22-078800
Jul 11, 202240001104659-22-078789
Jul 11, 2022POS AM0001140361-22-025737
Jul 11, 2022POS AM0001140361-22-025729
Jul 11, 202240001104659-22-078801
Jul 11, 2022S-8 POS0001140361-22-025743
Jul 11, 20228-K0001140361-22-025725
Jul 11, 2022S-8 POS0001140361-22-025745
Jul 11, 202240001104659-22-078788
Jul 11, 202240001104659-22-078794
Jul 11, 202240001104659-22-078802
Jul 11, 2022S-8 POS0001140361-22-025739
Jul 11, 2022SC 13D/A0001140361-22-025754
Jul 11, 2022S-8 POS0001140361-22-025747
Jul 11, 202225-NSE0001354457-22-000389